[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568875":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":37,"centralContacts":41,"locations":46,"responsibleParty":64,"collaborators":67,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":75,"acronym":30,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":30,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":30,"overallStatus":48,"whyStopped":30,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"West Virginia University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Cannabidiol (CBD) Oil 300mg","ACTIVE_COMPARATOR","Cannabidiol (CBD) Oil, 300mg, 1 dose, 120 minutes prior to testing. After consumption of the respective treatment drug, the participant will be given a standardized meal and wait for 120 minutes to allow for drug absorption and for CBD to begin taking effect; this time frame was chosen based on the pharmacokinetics of CBD along with the consideration of participant burden (max absorption 2-5 hours; average half-life 17 hours).",[13],"Drug: Cannabidiol (CBD) Oil 300mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Cannabidiol (CBD) Oil 150mg","Cannabidiol (CBD) Oil, 150mg, 1 dose, 120 minutes prior to testing. After consumption of the respective treatment drug, the participant will be given a standardized meal and wait for 120 minutes to allow for drug absorption and for CBD to begin taking effect; this time frame was chosen based on the pharmacokinetics of CBD along with the consideration of participant burden (max absorption 2-5 hours; average half-life 17 hours).",[18],"Drug: Cannabidiol (CBD) Oil 150mg",{"label":20,"type":21,"description":22,"interventionNames":23},"Placebo Oil","PLACEBO_COMPARATOR","Placebo Oil 1 dose 120 minutes prior to testing. After consumption of the respective treatment drug\u002Fplacebo, the participant will be given a standardized meal and wait for 120 minutes to allow for drug absorption and for CBD to begin taking effect; this time frame was chosen based on the pharmacokinetics of CBD along with the consideration of participant burden (max absorption 2-5 hours; average half-life 17 hours).",[24],"Drug: Placebo Oil",[26,31,34],{"type":27,"name":9,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","Cannabidiol (CBD) Oil 300mg, 1 dose",[9],null,{"type":27,"name":15,"description":32,"armGroupLabels":33,"otherNames":30},"Cannabidiol (CBD) Oil 150mg, 1 dose",[15],{"type":27,"name":20,"description":35,"armGroupLabels":36,"otherNames":30},"Placebo Oil, 1 dose",[20],[38],{"name":39,"affiliation":5,"role":40},"Toni M Rudisill, PhD","PRINCIPAL_INVESTIGATOR",[42],{"name":39,"role":43,"phone":44,"phoneExt":30,"email":45},"CONTACT","3042930687","trudisill@hsc.wvu.edu",[47],{"facility":5,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"RECRUITING","Morgantown","West Virginia","26506","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-79.9559,39.62953,{"lat":58,"lon":57},[61,63],{"name":39,"role":43,"phone":62,"phoneExt":30,"email":45},"304-293-0687",{"name":39,"role":40,"phone":30,"phoneExt":30,"email":30},{"type":40,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Toni Marie Rudisill","Associate Professor",[68],{"name":69,"class":70},"National Institute on Drug Abuse (NIDA)","NIH","100568875","phase-1-the-effects-of-cannabidiol-on-the-driving-performance-of-healthy-adults-by-dose-and-sex-100568875",false,"NCT06686914","The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex","Inclusion Criteria:\n\n* Possess a current drivers' license\n* Driven a motor vehicle at least once in the past 30 days\n* Able to read English\n* Test negative for all substances on a urine drug test and complete a test drive to ensure the absence of simulation sickness\n* Not taking any daily prescription medications (excluding birth control)\n* Not diagnosed with any serious chronic disease by a licensed healthcare provider (including but not limited to Alzheimer's and related dementias, Parkinson's disease or other neurodegenerative disorder, major depressive or anxiety disorder, schizophrenia or other serious mental illness, arrhythmias, cataracts, glaucoma, chronic obstructive pulmonary disease, diabetes, epilepsy, sleep apnea, and fibromyalgia)\n* Have an individual willing to drive them home after testing or be taken home by study staff after testing\n\nExclusion Criteria:\n\n* Currently smoke, vape or use tobacco products, used CBD in the past 30 days\n* Used illegal drugs in the past 30 days (e.g., cocaine\u002Fcrack, heroin, methamphetamine, 3,4-methylenedioxy-methamphetamine, inhalants, phencyclidine, lysergic acid diethylamide, psilocybin mushrooms, or marijuana)\n* Are pregnant or lactating at time of study",true,"ALL","18 Years","30 Years",{"count":82,"type":83},300,"ESTIMATED","INTERVENTIONAL",[86],"PHASE1","The objectives\u002Fpurpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.",[89,90],"Cannabidiol Effects","Driving Performance","2025-10-29",{"date":93,"type":94},"2025-10-31","ACTUAL",{"date":96,"type":94},"2025-06-30",{"date":98,"type":83},"2029-05-01",{"name":5,"class":6},1]